Xcout Intel
Resilience Therapeutics, Inc.
Resilience Therapeutics, Inc. operates as a biomanufacturing contract development and manufacturing organization (CDMO) that provides drug substance and drug product manufacturing services for biologics and cell therapies. The company serves biopharmaceutical clients by offering end-to-end development, scale-up, fill/finish, and supply chain solutions to help commercialize complex medicines.
Subscribe to see Resilience Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Resilience Therapeutics, Inc. at a glance
Resilience Therapeutics, Inc. is a biotech company headquartered in United States. It has raised at least $3.4M across the 2 funding rounds on record. Its most recent funding round raised $500,000 in February 2016. Xcout tracks 9 named people at Resilience Therapeutics, Inc., including William S. Marth (Chief Executive Officer). Xcout recorded 11 job postings from Resilience Therapeutics, Inc. in the last 90 days.
Resilience Therapeutics, Inc. leadership
- William S. MarthChief Executive Officer
- Andrew MontoneChief Financial Officer
- Jimmy WangChief Information Officer
- Junan GuoChief Quality Officer
- Mari Carmen PizarroChief Human Resources Officer
- Ori SolomonExecutive Vice President, Chief Legal & Administrative Officer
3 more named people on record for Resilience Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Resilience Therapeutics, Inc. funding rounds
At least $3.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $500,000 | — | |
| SEC Form D filing | $2.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Resilience Therapeutics, Inc.
Xcout recorded 11 job postings from Resilience Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Resilience Therapeutics, Inc.'s hiring signals →
Resilience Therapeutics, Inc. competitors
A few of Resilience Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.
Rezon Bio is a European biologics contract development and manufacturing organization (CDMO) that provides scalable, cost-efficient solutions for biologics programs. The company operates GMP-certified manufacturing sites in Warsaw and Gdańsk, Poland.
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Get Resilience Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Resilience Therapeutics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Resilience Therapeutics, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access